Key facts
- It has raised $13.9M; the latest was Later Stage VC in Oct 2025.
- Notable investors include Suzhou Oriza Holdings Corporation, Suzhou Guofa Venture Capital, Nantong Zijing Capital, Suzhou Trust, Cenova Capital — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Agibot Medical Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Agibot Medical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Agibot Medical Technology
Manufacturer of intelligent surgical robots intended for clinical applications in minimally invasive procedures. The company develops and commercialises laparoscopic surgical robots and related systems, integrating mechanics, electronics, optics, computing and software, thereby supporting precise, affordable and user-centred surgical interventions across medical institutions.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2020
- Website
- agibot.cn/
- Ownership
- Privately Held (backing)
Agibot Medical Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Agibot Medical Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Agibot Medical Technology in its N-PORT filings yet. We sweep new filings monthly.